Ken Griffin's top holdings (June 2025) include Charles Schwab Corp. (SCHW), a multinational financial services company.

Ken Griffin is the founder of Citadel, a global investment firm. He serves as the Chief Executive Officer of the company, which focuses on a variety of investment strategies across diverse asset classes.

Charles Schwab Corp. (SCHW)

Charles Schwab Corporation provides wealth management, securities brokerage, banking, and financial advisory services. The company serves individuals and institutions through its subsidiaries. Charles Schwab has a market capitalization of $160.51B, with Ken Griffin's position currently valued at $1.81B. The company's discounted cash flow analysis suggests a value of $175.82 per share.

Here's an overview of Ken Griffin's trades in Charles Schwab Corp.:

Invesco Capital Management LLC - Invesco QQQ Trust Series 1 (QQQ)

The Invesco QQQ Trust Series 1 is an exchange-traded fund (ETF) that tracks the Nasdaq-100 Index. It offers investors exposure to some of the largest non-financial companies listed on the Nasdaq. The fund's market cap stands at $15.29M, while the current value of Ken Griffin's holding is $1.26B.

Here's an overview of Ken Griffin's trades in Invesco Capital Management LLC:

Hess Corporation (HES)

Hess Corporation is a global independent energy company involved in the exploration, development, production, transportation, and sale of crude oil and natural gas. The corporation's operations are primarily located in the United States, Guyana, and Southeast Asia. Hess Corporation has a market capitalization of $40.88B, with Ken Griffin's position currently valued at $1.11B. Analysts have set a price target of $163.0 for Hess Corporation. The company's discounted cash flow analysis suggests a value of $110.03 per share.

Here's an overview of Ken Griffin's trades in Hess Corporation:

Edwards Lifesciences Corp (EW)

Edwards Lifesciences is a medical technology company specializing in artificial heart valves and hemodynamic monitoring. The company's products are used to treat advanced cardiovascular diseases. Edwards Lifesciences Corp has a market cap of $45.88B, while this holding in Ken Griffin's portfolio is currently worth $1.05B. Analysts have set a price target of $75.0 for Edwards Lifesciences Corp. The company's discounted cash flow analysis suggests a value of $33.16 per share.

Here's an overview of Ken Griffin's trades in Edwards Lifesciences Corp:

Keurig Dr Pepper Inc (KDP)

Keurig Dr Pepper Inc. is a beverage company that manufactures, markets, and distributes a variety of hot and cold beverages. Their brand portfolio includes Keurig, Dr Pepper, Canada Dry, and Mott's. Keurig Dr Pepper Inc has a market capitalization of $45.73B, with Ken Griffin's position currently valued at $725.84M. Analysts have set a price target of $38.0 for Keurig Dr Pepper Inc. The company's discounted cash flow analysis suggests a value of $61.05 per share.

Here's an overview of Ken Griffin's trades in Keurig Dr Pepper Inc: